Michael Lefenfeld

Insider Reports History

Location: Exton, PA
Signature: /s/ Purnanand D. Sarma, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Lefenfeld:

Form 4 holding Director

Immunome Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 6,500
Estimated value
Report date: 08 Jun 2023
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Michael Lefenfeld

4 IMNM

Immunome Inc.

Report period: 08 Jun 2023
Transactions: 1
Transaction value: $0
Filing time: 12 Jun 2023, 16:55
Role: Director
Next action: Open filing details

4 IMNM

Immunome Inc.

Report period: 15 Jan 2023
Transactions: 1
Transaction value: +$55,500
Filing time: 17 Jan 2023, 05:28
Role: Director
Next action: Open filing details

4 IMNM

Immunome Inc.

Report period: 16 Jun 2022
Transactions: 1
Transaction value: $0
Filing time: 21 Jun 2022, 18:02
Role: Director
Next action: Open filing details

4 IMNM

Immunome Inc.

Report period: 28 May 2021
Transactions: 1
Transaction value: $0
Filing time: 01 Jun 2021, 20:04
Role: Director
Next action: Open filing details

4 IMNM

Immunome Inc.

Report period: 24 May 2021
Transactions: 3
Transaction value: +$86,150
Filing time: 26 May 2021, 21:32
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .